TABLE 1.
SUBJECT CHARACTERISTICS
| Severe Asthmatics
|
P value | ||||
|---|---|---|---|---|---|
| H/H | H/L | L/H | L/L | ||
| N= 41 | 11 | 10 | 11 | 9 | |
| Gender | |||||
| Male/Female | 5/6 | 3/7 | 5/6 | 4/5 | 0.88 |
| Race | |||||
| Caucasian/ African American/ Other | 9/2/0 | 7/2/1 | 8/3/0 | 7/1/1 | 0.93 |
| Age (yr) | 34.6±4.9 | 36.9±3.7 | 43.0±5.8 | 31.7±6.0 | 0.47 |
| Age Onset | 12.7±3.9 | 11.8±5.7 | 23.7±6.7 | 10.9±6.5 | 0.35 |
| Duration | 21.8±5.5 | 27.0±3.3 N=9 |
19.3±3.9 | 20.7±4.9 | 0.68 |
| BMI | 28.1±1.4 | 31.3±2.1 | 28.4±2.1 | 29.1±2.0 | 0.64 |
| Lung Function: | |||||
| FEV1 % predicted | 56.3±7.5 | 54.6±7.7 | 68.9±7.0 | 66.7±9.3 | 0.47 |
| FVC % predicted | 76.3±7.7 | 72.5±8.7 | 80.3±6.9 | 89.4±10.5 | 0.56 |
| FEV1/FVC | 0.6±0.04 | 0.6±0.04 | 0.7±0.03 | 0.6±0.03 | 0.19 |
| Corticosteroid Use (Yes/No): | |||||
| Inhaled | 11/0 | 9/1 | 10/1 | 9/0 | 0.60 |
| Systemic | 8/3 | 9/1 | 5/6 | 6/3 | 0.19 |
Definition of Abbreviations: BMI= body mass index, FEV1= forced expiratory volume in 1 second, FVC= forced vital capacity
Mean ± SEM are shown and the number of subjects is indicated if information was not available for all subjects in the group.